Alpine Immune Sciences Earnings Perspective: Return On Capital Employed
Alpine Immune Sciences (NASDAQ:ALPN) brought in sales totaling $4.53 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 12.4%, resulting in a loss of $15.17 million.
Benzinga ·
Benzinga
